Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation
NCT06119802 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2023-11-07
Summary
To clarify the predictive effects of uric acid and superoxide dismutase as biomarkers of oxidative stress on atrial fibrillation, and to provide greater value for the diagnosis and prediction of atrial fibrillation. It provides a new idea for the prevention and treatment of atrial fibrillation.
Conditions
- Atrial Fibrillation
- Hyperuricemia
Interventions
- DIAGNOSTIC_TEST
-
ECG of atrial fibrillation last more than 30 seconds.
Sponsors & Collaborators
-
Yinglong Hou
lead OTHER
Principal Investigators
-
Hui Tian, PhD · Qianfoshan Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2023-10-31
- Completion
- 2024-04-30
Countries
- China
Study Locations
More Related Trials
-
DOAC in Chinese Patients With Atrial Fibrillation
NCT05378035 ·Status: RECRUITING
-
CD-NP in Subjects With Stable Chronic Heart Failure
NCT00620308 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271 ·Status: COMPLETED
-
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure
NCT06137430 ·Status: NOT_YET_RECRUITING
-
Therapeutic Drug Monitoring of Cardiac Medications
NCT03667781 ·Status: TERMINATED
-
Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study
NCT04426084 ·Status: UNKNOWN
-
Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation
NCT06759909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT04684056 ·Status: UNKNOWN
-
Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation
NCT06280768 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation
NCT06740786 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Biomarker Guided Therapies in Stage A/B Heart Failure
NCT02230891 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Carvedilol Rapid Up-Titration in Patients With Heart Failure With Reduced Ejection Fraction
NCT05179070 ·Status: UNKNOWN ·Phase: PHASE4
-
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
NCT02262078 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients
NCT00477789 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin
NCT05357911 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
NCT02256345 ·Status: COMPLETED ·Phase: PHASE2
-
CoQ10 and D-ribose in Patients With Diastolic Heart Failure
NCT03133793 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
NCT06108414 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure
NCT01092325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical Study
NCT04125966 ·Status: UNKNOWN
-
Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
NCT06111768 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Recombinant BNP on Heart and Renal Function in Acute Heart Failure
NCT01625403 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomarkers in Acute Heart Failure
NCT00537628 ·Status: COMPLETED
-
A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction
NCT02980068 ·Status: COMPLETED ·Phase: PHASE1
-
Matching Perfusion and Metabolic Activity in HFpEF
NCT04913805 ·Status: RECRUITING ·Phase: PHASE2